Cargando…
A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis
BACKGROUND: Severe alcoholic hepatitis (AH) has a high short-term mortality rate. The MELD assesses disease severity and mortality; however, it is not specific for AH. We screened plasma samples from patients with severe AH for biomarkers of multiple pathological processes and identified predictors...
Autores principales: | Tornai, David, Mitchell, Mack, McClain, Craig J., Dasarathy, Srinivasan, McCullough, Arthur, Radaeva, Svetlana, Kroll-Desrosiers, Aimee, Lee, JungAe, Barton, Bruce, Szabo, Gyongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666984/ https://www.ncbi.nlm.nih.gov/pubmed/37994498 http://dx.doi.org/10.1097/HC9.0000000000000296 |
Ejemplares similares
-
Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis()()()
por: Tu, Wanzhu, et al.
Publicado: (2023) -
Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease
por: Mrdjen, Marko, et al.
Publicado: (2023) -
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
por: Miyata, Tatsunori, et al.
Publicado: (2021) -
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
por: Miyata, Tatsunori, et al.
Publicado: (2022) -
Emerging medical therapies for severe alcoholic hepatitis
por: Tornai, David, et al.
Publicado: (2020)